6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Ordered micropattern arrays fabricated by lung-derived dECM hydrogels for chemotherapeutic drug screening

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          This study aims to evaluate ECM-coated micropattern arrays derived from decellularization of native porcine lungs as a novel three-dimensional cell culture platform.

          Methods

          ECM derived from decellularization of native porcine lungs was exploited to prepare hydrogels. Then, dECM-coated micropattern arrays were fabricated at four different diameters (50, 100, 150 and 200 ​μm) using polydimethylsiloxane (PDMS). Two lung cancer cell lines, A549 and H1299, were tested on a dECM-coated micropattern array as a novel culture platform for cell adhesion, distribution, proliferation, viability, phenotype expression, and drug screening to evaluate the cytotoxicity of paclitaxel, doxorubicin and cisplatin.

          Results

          The ECM derived from decellularization of native porcine lungs supported cell adhesion, distribution, viability and proliferation better than collagen I and Matrigel as the coated matrix on the surface. Moreover, the optimal diameter of the micropattern arrays was 100–150 ​μm, as determined by measuring the morphology, viability, proliferation and phenotype of the cancer cell spheroids. Cell spheroids of A549 and H1299 on dECM-coated micropattern arrays showed chemoresistance to anticancer drugs compared to that of the monolayer. The different distributions of HIF-1α, MCL-1 (in the center) and Ki-67 and MRP2 (in the periphery) of the spheroids demonstrated the good establishment of basal-lateral polarity and explained the chemoresistance phenomenon of spheroids.

          Conclusions

          This novel three-dimensional cell culture platform is stable and reliable for anticancer drug testing. Drug screening in dECM-coated micropattern arrays provides a powerful alternative to existing methods for drug testing and metabolic profiling in the drug discovery process.

          Graphical abstract

          Highlights

          • Lung dECM hydrogels can be used as a beneficial coating matrix for supporting cell adhesion, viability and proliferation.

          • Ordered micropattern arrays provide a novel platform for spheroid formation, phenotype expression and drug screening.

          • The heterogeneous distributions of the cancer spheroids established basal-lateral polarity and explained the chemoresistance.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Revisiting the role of ABC transporters in multidrug-resistant cancer

          Most patients who die of cancer have disseminated disease that has become resistant to multiple therapeutic modalities. Ample evidence suggests that the expression of ATP- binding cassette (ABC) transporters, especially the multidrug resistance protein 1 (MDR1, also known as P- glycoprotein or P-gp), which is encoded by ABC subfamily B member 1 ( ABCB1 ), can confer resistance to cytotoxic and targeted chemotherapy. However, the development of MDR1 as a therapeutic target has been unsuccessful. At the time of its discovery, appropriate tools for the characterization and clinical development of MDR1 as a therapeutic target were lacking. Thirty years after the initial cloning and characterization of MDR1 and the implication of two additional ABC transporters, the multidrug resistance associated protein 1 (MRP1; encoded by ABCC1 )), and ABCG2, in multidrug resistance, interest in investigating these transporters as therapeutic targets has waned. However, with the emergence of new data and advanced techniques, we propose to re- evaluate whether these transporters play a clinical role in multidrug resistance. With this Opinion article, we present recent evidence indicating that it is time to revisit the investigation into the role of ABC transporters in efficient drug delivery in various cancer types and at the blood–brain barrier.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Multidrug resistance in cancer: role of ATP-dependent transporters.

            Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs--a trait known as multidrug resistance--remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Macrophages and therapeutic resistance in cancer.

              How neoplastic cells respond to therapy is not solely dependent on the complexity of the genomic aberrations they harbor but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments. Therefore, therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways identified so far whereby macrophages mediate therapeutic responses. Copyright © 2015 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                Journal
                Mater Today Bio
                Mater Today Bio
                Materials Today Bio
                Elsevier
                2590-0064
                05 May 2022
                June 2022
                05 May 2022
                : 15
                : 100274
                Affiliations
                [a ]Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
                [b ]Institute of Respiratory Health, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
                [c ]Precision Medicine Key Laboratory, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China
                [d ]West China School of Medicine, Sichuan University, Chengdu, 610041, Sichuan, China
                [e ]Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China
                Author notes
                []Corresponding author. Institute of Clinical Pathology, West China Hospital, Sichuan University, 37# Guoxue Road, Chengdu, 610041, Sichuan Province, China. baoji@ 123456scu.edu.cn
                [∗∗ ]Corresponding author. Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, 37# Guoxue Road, Chengdu 610041, Sichuan Province, China. weimi003@ 123456scu.edu.cn
                [1]

                The authors contributed equally to this work.

                Article
                S2590-0064(22)00072-2 100274
                10.1016/j.mtbio.2022.100274
                9114688
                35601895
                43ff86f1-04c0-42fc-a6c6-1a007cc412e0
                © 2022 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 12 February 2022
                : 25 April 2022
                : 26 April 2022
                Categories
                Full Length Article

                extracellular matrix,lung,decellularization,cancer cell,drug screening

                Comments

                Comment on this article